Results 61 to 70 of about 11,092 (219)
Linfoma angiocéntrico centrofacial [PDF]
, 2005 El linfoma angiocéntrico centrofacial es una neoplasia linfoide rara, con un diagnóstico a menudo difícil, debido al cuadro clínico inespecífico y a que muchas veces son necesarias varias biopsias para llegar a un diagnóstico correcto.
Crespo Pinilla, J.I. +4 more
core +1 more source
Classification of haematopoietic and lymphoid tumors: WHO, standardization of nomenclature in Portuguese, 4th edition [PDF]
, 2011 INTRODUCTION: The World Health Organization (WHO) classification of hematopoietic and lymphoid tissue (4th edition, 2008) tumors constitutes an updated review of the 3rd edition published in 2001.
Aldred, Vera Lucia +13 more
core +2 more sources
Hematological Oncology, Volume 42, Issue 2, March 2024.Abstract Chronic lymphocytic leukemia (CLL) is the most common leukemia in western societies, recognized by clinical and molecular heterogeneity. Despite the success of targeted therapies, acquired resistance remains a challenge for relapsed and refractory CLL, as a consequence of mutations in the target or the upregulation of other survival pathways ...
Nayla Mouawad +6 more
wiley +1 more source
Síndrome ocular mascarada devido linfoma intra-ocular: relato de casos [PDF]
, 2007 Ocular masquerade syndrome was diagnosted in two patients with chronic uveitis. The patients presented non-Hodgkin's lymphoma as the final diagnosis two forms of intraocular retinal pigment epithelium involvement was seen.
Abreu, Mariza Toledo +2 more
core +2 more sources
Antibody targeting of mutant calreticulin in myeloproliferative neoplasms
Journal of Cellular and Molecular Medicine, Volume 28, Issue 5, March 2024.Overview of pathogenic mechanisms of mutant calreticulin (CALR) in myeloproliferative neoplasms (MPN) and potential ways to target the mutant calreticulin neoantigen by therapeutic monoclonal antibodies (mAb). 1: Mutant calreticulin is secreted and functions as an immunosuppressor. The mutant calreticulin novel C‐terminus is shown in red.
Frederike Kramer, Ann Mullally
wiley +1 more source
Linfoma gástrico no Hodgkin perforado
, 2017 Los linfomas son tumores sólidos del sistema linfático y se subdividen en linfomas de Hodgkin y no-Hodgkin. Los tumores no Hodgkin pueden originarse en tejidos no ganglionares como el tubo digestivo y son considerados primarios cuando el compromiso extranodal es igual o superior al 75% con relación al compromiso nodal.
Lizarzaburu Rodríguez, Víctor M. +4 more
openaire +3 more sources
Revista de Osteoporosis y Metabolismo Mineral, 2017 La afectación esquelética en los pacientes con linfoma no hodgkiniano (LNH) no es infrecuente. Suele ser una manifestación tardía, y cuando aparece lo hace generalmente de forma secundaria por linfomas en estadio avanzado y con alta carga tumoral.
Rodríguez Duque JC +5 more
doaj +1 more source
Factores pronósticos en el linfoma de Hodgkin. Revisión de una serie clínica [PDF]
, 2019 El linfoma de Hodgkin (LH) es un tipo de neoplasia maligna de origen clonal, que deriva de los linfocitos B del centro germinal de los ganglios linfáticos y constituye el 10% de todos los linfomas.
Antón Rodríguez, Ángela +1 more
core
Leucemia Linfoblástica aguda recidivada tratada com rituximab: relato de caso e revisão de literatura. [PDF]
, 2007 Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Borbinhão, Rodrigo Widholzer
core
Primary Effusion Lymphoma in a HIV Infected Patient [PDF]
, 2012 O linfoma primário das cavidades é um subtipo de linfoma não-Hodgkin (LNH), de ocorrência rara, prognóstico muito reservado, mais frequentemente descrito em indivíduos imunodeprimidos, em particular no contexto de infecção pelo vírus da imunodeficiência
Castro, M +4 more
core